Appleton Partners Inc. MA Sells 468 Shares of CVS Health Co. (NYSE:CVS)

Appleton Partners Inc. MA trimmed its position in shares of CVS Health Co. (NYSE:CVS) by 10.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 4,167 shares of the pharmacy operator’s stock after selling 468 shares during the period. Appleton Partners Inc. MA’s holdings in CVS Health were worth $246,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. USA Financial Formulas boosted its position in shares of CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. bought a new stake in shares of CVS Health in the 4th quarter worth approximately $32,000. Creekmur Asset Management LLC bought a new stake in shares of CVS Health in the 4th quarter worth approximately $34,000. Steph & Co. boosted its position in shares of CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares in the last quarter. Finally, Kapitalo Investimentos Ltda bought a new position in CVS Health in the 4th quarter valued at approximately $36,000. 80.66% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CVS has been the topic of several analyst reports. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $58.00 price objective on shares of CVS Health in a research report on Tuesday, July 23rd. Leerink Partnrs lowered shares of CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 1st. The Goldman Sachs Group reduced their price objective on CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. SVB Leerink restated a “market perform” rating and issued a $60.00 price objective (down from $87.00) on shares of CVS Health in a research note on Wednesday, May 1st. Finally, Robert W. Baird began coverage on CVS Health in a research note on Thursday, May 30th. They issued a “neutral” rating and a $61.00 price objective for the company. Eleven analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $75.05.

CVS Health Trading Down 1.2 %

Shares of NYSE:CVS traded down $0.71 during trading on Friday, reaching $59.32. 8,695,521 shares of the company were exchanged, compared to its average volume of 9,014,376. The firm has a market capitalization of $74.47 billion, a PE ratio of 10.43, a P/E/G ratio of 0.57 and a beta of 0.52. The business’s fifty day simple moving average is $59.27 and its 200-day simple moving average is $66.79. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The company had revenue of $88.44 billion for the quarter, compared to analysts’ expectations of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business’s revenue was up 3.7% compared to the same quarter last year. During the same period last year, the business posted $2.20 earnings per share. On average, research analysts anticipate that CVS Health Co. will post 7 EPS for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.48%. The ex-dividend date of this dividend was Monday, July 22nd. CVS Health’s payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.